(NEW YORK)Shares of Biodel Inc. moved lower Thursday as Oppenheimer & Co. echoed continued concern on Wall Street over the company's late-stage program for the diabetes treatment Viaject.READ MORE
Among the stock activity stories for Thursday, Sept. 11, from AP Financial News: NEW YORK (AP)--Shares in Landauer Inc., which provides radiation detection services, jumped Thursda...READ MORE
Among the stock activity stories for Monday, Sept. 8, from AP Financial News: NEW YORK (AP)--Shares of Regions Financial Corp. soared Monday following the government's takeover of ...READ MORE
(NEW YORK)Shares of Biodel Inc. plummeted to an all-time low Monday as investors appeared to doubt the future of Biodel's diabetes drug candidate based on new clinical trial results.READ MORE
Among the stock activity stories for Monday, Sept. 8, from AP Financial News: NEW YORK (AP)--Shares of Alvarion Ltd. jumped Monday after an Oppenheimer & Co. analyst upgraded the I...READ MORE
Among the earnings stories for Thursday, Aug. 7, from AP Financial News: HOUSTON (AP)--Oil and natural-gas producer Swift Energy Co. said Thursday its second-quarter profit more th...READ MORE
(DANBURY, Conn.)Drug developer Biodel Inc. said late Wednesday its fiscal 2008 third-quarter loss widened on higher costs related to the late-stage development of its injectable insulin.READ MORE